Publications by authors named "Kristin Narayan"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

12

Total Likes

0

Extended Reach

1,457

Social Features

2
S
Safety, Pharmacokinetics, Serum Neutralizing Titers, and Immunogenicity of Adintrevimab, a Monoclonal Antibody Targeting SARS-CoV-2: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Dose-escalation Study in Healthy Adults.
Pete Schmidt, Jean Gong, Kristin Narayan, Deepali Gupta, Frank Engler, Yong Li, Amanda Copans, Ed Campanaro

Infect Dis Ther· May 2023

Videos about Article: user

1 1

View All Article and Social Media Activity
S
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY).
Cameron R Wolfe, Jonathan Cohen, Kathryn Mahoney, Anna Holmes, Natalia Betancourt, Kristin Narayan

Clin Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE).
Michael G Ison, Debra F Weinstein, Marta Dobryanska, Anna Holmes, Anne-Marie Phelan, Kristin Narayan

Open Forum Infect Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron.
Michael G Ison, Myra Popejoy, Nikolay Evgeniev, Maria Tzekova, Kathryn Mahoney, Kristin Narayan

Open Forum Infect Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers.
Pete Schmidt, Kristin Narayan, Yong Li, Chengzi I Kaku, Michael E Brown

Sci Transl Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19.
Elizabeth E Zumbrun, Chengzi I Kaku, Lukas Dillinger, Samantha E Zak, Ana I Kuehne, Kristin Narayan

Antimicrob Agents Chemother· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers.
Pete Schmidt, Kristin Narayan, Yong Li, Chengzi Kaku, Michael Brown

medRxiv· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study.
Susan E Sloan, Kristy J Szretter, Bharathi Sundaresh, Kristin M Narayan, Patrick F Smith

Antiviral Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study.
Ellie Hershberger, Susan Sloan, Kristin Narayan, Catherine A Hay, Patrick Smith

EBioMedicine· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extending human IgG half-life using structure-guided design.
Brian J Booth, Boopathy Ramakrishnan, Kristin Narayan, Andrew M Wollacott, Gregory J Babcock

MAbs· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.
Ema T Crooks, Tommy Tong, Bimal Chakrabarti, Kristin Narayan, Ivelin S Georgiev

PLoS Pathog· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1.
Johannes S Gach, Heribert Quendler, Tommy Tong, Kristin M Narayan, Sean X Du

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prime-boost immunization of rabbits with HIV-1 gp120 elicits potent neutralization activity against a primary viral isolate.
Kristin M Narayan, Nitish Agrawal, Sean X Du, Janelle E Muranaka, Katherine Bauer

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis